요관 스텐트 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 용도별, 지역별, 부문별 예측(2025-2030년)

Ureteral Stents Market Size, Share & Trends Analysis Report By Material (Metallic, Polymer), By Application (Kidney Stones, Kidney Transplantation, Urinary Incontinence), By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

요관 스텐트 시장 성장과 동향:

Grand View Research, Inc의 최신 보고서에 따르면 세계 요관 스텐트 시장 규모는 2030년까지 8억 5,330만 달러에 달할 것으로 예상되며, 연평균 6.9%의 CAGR로 확대될 것으로 예측됩니다.

신장결석, 요실금, 종양 등 비뇨기과 질환의 발생률 증가가 시장을 주도하고 있습니다. 요관 스텐트는 막힌 요관을 통해 소변의 흐름을 복원하고 요관의 개통성을 유지하기 위해 비뇨기과 수술 시 사용됩니다. 신장 결석, 요실금, 신장 이식 등 여러 질환에 사용됩니다. 이러한 질환의 유병률이 증가함에 따라 시장은 예측 기간 동안 큰 성장률을 보일 것으로 예상됩니다.

또한, 노인 인구는 신장 결석과 같은 비뇨기 및 신장 관련 문제가 발생할 위험이 높습니다. 따라서 노인 인구의 증가는 시장을 견인할 것으로 예상됩니다. 예를 들어, 세계보건기구(WHO) 보고서 2018에 따르면, 60세 이상 인구는 2015년 9억 명에서 2050년 20억 명에 달할 것으로 예측됩니다. 이는 예측 기간 동안 시장 성장을 촉진할 것으로 예상됩니다.

또한, 시장 진입 기업들의 신기술 도입과 신제품 출시는 시장 성장을 촉진할 것으로 예상됩니다. 예를 들어, 2019년 보스턴 사이언티픽(Boston Scientific)은 일회용 디지털 연성 요관경과 함께 신장 결석 회수 시술에 사용되는 LithoVue Empower 회수 전개 장치를 발표했습니다.

요관 스텐트 시장 보고서 하이라이트:

• 재료별로는 폴리머 스텐트가 2024년 67.0%의 점유율을 차지하며 시장을 장악했습니다.
• 용도별로는 신장 결석 분야가 2024년 37.0%의 점유율을 차지하며 시장을 주도했습니다. 이는 신장 결석 및 관련 수술로 이어지는 식습관과 같은 좌식 생활 방식의 채택이 증가하고 있기 때문입니다.
• 북미는 신장 관련 질환의 증가와 이 지역의 최신 치료법의 가용성으로 인해 2024년 36.3%의 가장 높은 매출 점유율을 차지하며 시장을 장악했습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 요관 스텐트 시장 변수, 동향, 범위

• 시장 계통 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 비즈니스 환경 분석
  • 업계 분석 - Porter's Five Forces 분석
  • PESTLE 분석

제4장 요관 스텐트 시장 : 재료 비즈니스 분석

• 재료 시장 점유율, 2024년과 2030년
• 재료 부문 대시보드
• 시장 규모와 예측 및 동향 분석, 재료별, 2018-2030년
• 금속 요관 스텐트
• 폴리머 요관 스텐트

제5장 요관 스텐트 시장 : 용도 비즈니스 분석

• 용도 시장 점유율, 2024년 및 2030년
• 용도 부문 대시보드
• 시장 규모와 예측 및 동향 분석, 용도별, 2018-2030년
• 신장 결석
• 신장 이식
• 종양
• 요실금
• 기타

제6장 요관 스텐트 시장 : 지역별 추정·동향 분석

• 지역별 시장 점유율 분석, 2024년 및 2030년
• 지역 시장 대시보드
• 시장 규모, 예측 동향 분석, 2018-2030년 :
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 노르웨이
  • 덴마크
  • 스웨덴
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제7장 경쟁 상황

• 진출 기업 개요
• 기업의 시장 포지션 분석
• 기업 분류
• 전략 매핑
• 기업 개요
  • Allium Medical
  • B.Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast
  • Cook Medical
  • Olympus Corporation
  • Pnn Medical A/S
  • Teleflex Inc.
  • Merit Medical Systems, Inc.

ksm

영문 목차

영문목차

Ureteral Stents Market Growth & Trends:

The global ureteral stents market size is anticipated to reach USD 853.3 million by 2030, expanding at a CAGR of 6.9%, according to a new report by Grand View Research, Inc. Rising incidence of urological diseases such as kidney stones, urinary incontinence, tumors is driving the market. Ureteral stents help in restoring the flow of urine through the blocked ureters and are utilized during urological surgeries to maintain the patency of the ureter. These are used for several medical conditions such as kidney stones, urinary incontinence, and kidney transplants. Thus, with the mounting prevalence of these incidences, the market is anticipated to witness a significant growth rate over the forecast period.

In addition, the geriatric population is at higher risk to develop urological and kidney-related issues such as kidney stones. Thus, the growing geriatric population is expected to drive the market. For instance, as per the WHO report 2018, the world base of population pertaining to the age group of 60 and above is anticipated to reach 2.0 billion by 2050 from 900.0 million in 2015. This is expected to propel market growth over the forecast period.

Furthermore, the incorporation of new technologies and introduction of new products by market players are expected to boost the market growth. For instance, in 2019, Boston Scientific has unveiled the LithoVue Empower retrieval deployment device which is utilized with company's single-use digital flexible ureteroscope during kidney stone retrieval procedures.

Ureteral Stents Market Report Highlights:

• Based on material, the polymer stents segment dominated the market with a share of 67.0% in 2024 owing to the high adoption of these stents during urological procedures due to its reduced rate of complications and infections
• On the basis of application, the kidney stones segment dominated the market with a share of 37.0% in 2024. This is due to an increase in the adoption of a sedentary lifestyle such as dietary habits that leads to kidney stones and associated surgeries
• North America dominated the market with the highest revenue share of 36.3% in 2024 owing to the increasing kidney-related illnesses, and availability of the latest treatment procedures in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Application
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Ureteral Stents Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrant
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. Ureteral Stents Market: Material Business Analysis

• 4.1. Material Market Share, 2024 & 2030
• 4.2. Material Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Material, 2018 to 2030 (USD Million)
• 4.4. Metallic Ureteral Stents
  • 4.4.1. Metallic Ureteral Stents Market, 2018 - 2030 (USD Million)
• 4.5. Polymer Ureteral Stents
  • 4.5.1. Polymer Ureteral Stents Market, 2018 - 2030 (USD Million)
  • 4.5.2. Silicone Stents
    • 4.5.2.1. Silicone Stents Market, 2018 - 2030 (USD Million)
  • 4.5.3. Polyurethane Stents
    • 4.5.3.1. Polyurethane Stents Market, 2018 - 2030 (USD Million)
  • 4.5.4. Hybrid Stents
    • 4.5.4.1. Hybrid Stents Market, 2018 - 2030 (USD Million)

Chapter 5. Ureteral Stents Market: Application Business Analysis

• 5.1. Application Market Share, 2024 & 2030
• 5.2. Application Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Kidney Stones
  • 5.4.1. Kidney Stones Market, 2018 - 2030 (USD Million)
• 5.5. Kidney Transplantation
  • 5.5.1. Kidney Transplantation Market, 2018 - 2030 (USD Million)
• 5.6. Tumors
  • 5.6.1. Tumors Market, 2018 - 2030 (USD Million)
• 5.7. Urinary Incontinence
  • 5.7.1. Urinary Incontinence Market, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Ureteral Stents Market: Regional Estimates & Trend Analysis

• 6.1. Regional Market Share Analysis, 2024 & 2030
• 6.2. Regional Market Dashboard
• 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 6.4. North America
  • 6.4.1. North America Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Regulatory Framework
    • 6.4.2.3. Competitive Insights
    • 6.4.2.4. U.S. Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Regulatory Framework
    • 6.4.3.3. Competitive Insights
    • 6.4.3.4. Canada Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Regulatory Framework
    • 6.4.4.3. Competitive Insights
    • 6.4.4.4. Mexico Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Regulatory Framework
    • 6.5.2.3. Competitive Insights
    • 6.5.2.4. UK Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Regulatory Framework
    • 6.5.3.3. Competitive Insights
    • 6.5.3.4. Germany Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Regulatory Framework
    • 6.5.4.3. Competitive Insights
    • 6.5.4.4. France Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Regulatory Framework
    • 6.5.5.3. Competitive Insights
    • 6.5.5.4. Italy Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Regulatory Framework
    • 6.5.6.3. Competitive Insights
    • 6.5.6.4. Spain Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Regulatory Framework
    • 6.5.7.3. Competitive Insights
    • 6.5.7.4. Norway Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Denmark
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Regulatory Framework
    • 6.5.8.3. Competitive Insights
    • 6.5.8.4. Denmark Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Sweden
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Regulatory Framework
    • 6.5.9.3. Competitive Insights
    • 6.5.9.4. Sweden Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Regulatory Framework
    • 6.6.2.3. Competitive Insights
    • 6.6.2.4. Japan Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Regulatory Framework
    • 6.6.3.3. Competitive Insights
    • 6.6.3.4. China Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Regulatory Framework
    • 6.6.4.3. Competitive Insights
    • 6.6.4.4. India Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Regulatory Framework
    • 6.6.5.3. Competitive Insights
    • 6.6.5.4. South Korea Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Regulatory Framework
    • 6.6.6.3. Competitive Insights
    • 6.6.6.4. Australia Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Regulatory Framework
    • 6.6.7.3. Competitive Insights
    • 6.6.7.4. Thailand Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Regulatory Framework
    • 6.7.2.3. Competitive Insights
    • 6.7.2.4. Brazil Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Regulatory Framework
    • 6.7.3.3. Competitive Insights
    • 6.7.3.4. Argentina Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. MEA
  • 6.8.1. MEA Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Regulatory Framework
    • 6.8.2.3. Competitive Insights
    • 6.8.2.4. South Africa Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Regulatory Framework
    • 6.8.3.3. Competitive Insights
    • 6.8.3.4. Saudi Arabia Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Regulatory Framework
    • 6.8.4.3. Competitive Insights
    • 6.8.4.4. UAE Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Regulatory Framework
    • 6.8.5.3. Competitive Insights
    • 6.8.5.4. Kuwait Ureteral Stents Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Position Analysis
• 7.3. Company Categorization
• 7.4. Strategy Mapping
• 7.5. Company Profiles/Listing
  • 7.5.1. Allium Medical
    • 7.5.1.1. Overview
    • 7.5.1.2. Financial Performance
    • 7.5.1.3. Material Benchmarking
    • 7.5.1.4. Strategic Initiatives
  • 7.5.2. B.Braun Melsungen AG
    • 7.5.2.1. Overview
    • 7.5.2.2. Financial Performance
    • 7.5.2.3. Material Benchmarking
    • 7.5.2.4. Strategic Initiatives
  • 7.5.3. Becton, Dickinson and Company
    • 7.5.3.1. Overview
    • 7.5.3.2. Financial Performance
    • 7.5.3.3. Material Benchmarking
    • 7.5.3.4. Strategic Initiatives
  • 7.5.4. Boston Scientific Corporation
    • 7.5.4.1. Overview
    • 7.5.4.2. Financial Performance
    • 7.5.4.3. Material Benchmarking
    • 7.5.4.4. Strategic Initiatives
  • 7.5.5. Coloplast
    • 7.5.5.1. Overview
    • 7.5.5.2. Financial Performance
    • 7.5.5.3. Material Benchmarking
    • 7.5.5.4. Strategic Initiatives
  • 7.5.6. Cook Medical
    • 7.5.6.1. Overview
    • 7.5.6.2. Financial Performance
    • 7.5.6.3. Material Benchmarking
    • 7.5.6.4. Strategic Initiatives
  • 7.5.7. Olympus Corporation
    • 7.5.7.1. Overview
    • 7.5.7.2. Financial Performance
    • 7.5.7.3. Material Benchmarking
    • 7.5.7.4. Strategic Initiatives
  • 7.5.8. Pnn Medical A/S
    • 7.5.8.1. Overview
    • 7.5.8.2. Financial Performance
    • 7.5.8.3. Material Benchmarking
    • 7.5.8.4. Strategic Initiatives
  • 7.5.9. Teleflex Inc.
    • 7.5.9.1. Overview
    • 7.5.9.2. Financial Performance
    • 7.5.9.3. Material Benchmarking
    • 7.5.9.4. Strategic Initiatives
  • 7.5.10. Merit Medical Systems, Inc.
    • 7.5.10.1. Overview
    • 7.5.10.2. Financial Performance
    • 7.5.10.3. Material Benchmarking
    • 7.5.10.4. Strategic Initiatives

관련자료